Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $18,920 | 1,182 | 99.7% |
| Education | $56.83 | 6 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,365 | 171 | $0 (2024) |
| Amgen Inc. | $2,026 | 94 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,578 | 99 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,393 | 85 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,272 | 82 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $1,068 | 73 | $0 (2023) |
| Lilly USA, LLC | $1,032 | 65 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $970.11 | 62 | $0 (2024) |
| ABBVIE INC. | $861.97 | 77 | $0 (2024) |
| PFIZER INC. | $752.36 | 65 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,856 | 96 | AstraZeneca Pharmaceuticals LP ($356.98) |
| 2023 | $2,205 | 125 | GlaxoSmithKline, LLC. ($325.10) |
| 2022 | $2,001 | 136 | Boehringer Ingelheim Pharmaceuticals, Inc. ($285.33) |
| 2021 | $2,699 | 172 | Amgen Inc. ($340.20) |
| 2020 | $1,880 | 142 | Novo Nordisk Inc ($375.57) |
| 2019 | $2,775 | 165 | Amgen Inc. ($591.61) |
| 2018 | $2,072 | 152 | Novo Nordisk Inc ($321.69) |
| 2017 | $3,489 | 200 | Novo Nordisk Inc ($420.87) |
All Payment Transactions
1,188 individual payment records from CMS Open Payments — Page 1 of 48
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: Respiratory | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/15/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: RESPIRATORY | ||||||
| 11/05/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/01/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/31/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: Respiratory | ||||||
| 10/30/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/22/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: Cardio-renal | ||||||
| 10/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $31.24 | General |
| Category: Oncology | ||||||
| 10/15/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: Diabetes | ||||||
| 10/09/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/09/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $30.23 | General |
| Category: Oncology | ||||||
| 10/08/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $11.38 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/04/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: PAIN | ||||||
| 10/03/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/23/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: Diabetes | ||||||
| 09/12/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/10/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: Gastroenterology | ||||||
| 09/05/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: Diabetes | ||||||
| 09/04/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 370 | 488 | $77,250 | $36,260 |
| 2022 | 9 | 432 | 570 | $87,390 | $41,016 |
| 2021 | 11 | 526 | 657 | $97,430 | $46,848 |
| 2020 | 11 | 590 | 752 | $109,825 | $48,658 |
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 91 | 159 | $31,800 | $15,525 | 48.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 69 | 113 | $16,950 | $7,822 | 46.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 49 | 49 | $12,250 | $6,968 | 56.9% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 50 | 50 | $10,000 | $4,166 | 41.7% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 51 | 51 | $2,040 | $1,062 | 52.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 11 | 11 | $550.00 | $373.67 | 67.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 29 | 32 | $3,200 | $270.06 | 8.4% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 20 | 23 | $460.00 | $73.83 | 16.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 92 | 163 | $32,600 | $16,120 | 49.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 96 | 155 | $23,250 | $10,344 | 44.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 48 | 48 | $12,000 | $7,016 | 58.5% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 45 | 45 | $9,000 | $3,746 | 41.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 21 | 21 | $3,150 | $1,439 | 45.7% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 50 | 50 | $2,000 | $1,058 | 52.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 24 | 25 | $1,250 | $842.94 | 67.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 35 | 36 | $3,600 | $361.99 | 10.1% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2022 | 21 | 27 | $540.00 | $87.75 | 16.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 88 | 145 | $29,000 | $15,134 | 52.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 98 | 155 | $23,250 | $10,803 | 46.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 56 | 56 | $14,000 | $8,350 | 59.6% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Office | 2021 | 68 | 68 | $13,600 | $5,692 | 41.8% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2021 | 11 | 11 | $3,300 | $2,073 | 62.8% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 21 | 22 | $2,750 | $1,427 | 51.9% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 59 | 59 | $2,360 | $1,273 | 53.9% |
| 90682 | Vaccine for influenza derived from dna for injection into muscle, quadrivalent, preservative and antibiotic free | Office | 2021 | 13 | 13 | $1,300 | $848.38 | 65.3% |
About James Perez
James Perez is a Internal Medicine healthcare provider based in Elizabeth, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1770546301.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, James Perez has received a total of $18,977 in payments from pharmaceutical and medical device companies, with $1,856 received in 2024. These payments were reported across 1,188 transactions from 62 companies. The most common payment nature is "Food and Beverage" ($18,920).
As a Medicare-enrolled provider, Perez has provided services to 1,918 Medicare beneficiaries, totaling 2,467 services with total Medicare billing of $172,781. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Elizabeth, NJ
- Active Since 04/06/2006
- Last Updated 12/15/2017
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1770546301
Products in Payments
- Ozempic (Drug) $1,214
- TRELEGY ELLIPTA (Drug) $820.75
- XARELTO (Drug) $671.86
- FARXIGA (Drug) $650.37
- JARDIANCE (Drug) $588.40
- Otezla (Drug) $555.66
- Victoza (Drug) $529.65
- TRULICITY (Drug) $507.63
- Kerendia (Drug) $490.81
- Prolia (Biological) $486.85
- Vascepa (Drug) $472.08
- XIFAXAN (Drug) $444.23
- EVENITY (Biological) $403.79
- LINZESS (Drug) $388.97
- Linzess (Drug) $366.07
- Rybelsus (Drug) $328.17
- INVOKANA (Drug) $327.35
- SYMBICORT (Drug) $308.61
- Aimovig (Biological) $307.66
- CHANTIX (Drug) $301.60
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Elizabeth
Sanjay Batta, M.d, M.D
Internal Medicine — Payments: $41,690
Dr. Francisco Munoz
Internal Medicine — Payments: $27,351
Ashraf Mansour, M.d, M.D
Internal Medicine — Payments: $22,769
Dr. Luis Benalcazar, M.d, M.D
Internal Medicine — Payments: $17,972
Mrs. Jean Pattathil, Md, MD
Internal Medicine — Payments: $14,602
Dr. Manish Patel, Md, MD
Internal Medicine — Payments: $12,243